Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis (Q69553161)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 August 1989
edit
Language Label Description Also known as
English
Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis
scientific article published on 01 August 1989

    Statements

    Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit